These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 23172306)
21. Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases. Schwettmann L; Wehmeier M; Jokovic D; Aleksandrova K; Brand K; Manns MP; Lichtinghagen R; Bahr MJ J Hepatol; 2008 Aug; 49(2):243-50. PubMed ID: 18490073 [TBL] [Abstract][Full Text] [Related]
22. MMP-2: is too low as bad as too high in the cardiovascular system? Hardy E; Hardy-Sosa A; Fernandez-Patron C Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1332-H1340. PubMed ID: 30118342 [TBL] [Abstract][Full Text] [Related]
27. The Biochemistry and Physiology of A Disintegrin and Metalloproteinases (ADAMs and ADAM-TSs) in Human Pathologies. Sharma D; Singh NK Rev Physiol Biochem Pharmacol; 2023; 184():69-120. PubMed ID: 35061104 [TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. Chavey C; Mari B; Monthouel MN; Bonnafous S; Anglard P; Van Obberghen E; Tartare-Deckert S J Biol Chem; 2003 Apr; 278(14):11888-96. PubMed ID: 12529376 [TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinases and ADAMs in stroke. Montaner J; Ramiro L; Simats A; Hernández-Guillamon M; Delgado P; Bustamante A; Rosell A Cell Mol Life Sci; 2019 Aug; 76(16):3117-3140. PubMed ID: 31165904 [TBL] [Abstract][Full Text] [Related]
30. ADAM12 redistributes and activates MMP-14, resulting in gelatin degradation, reduced apoptosis and increased tumor growth. Albrechtsen R; Kveiborg M; Stautz D; Vikeså J; Noer JB; Kotzsh A; Nielsen FC; Wewer UM; Fröhlich C J Cell Sci; 2013 Oct; 126(Pt 20):4707-20. PubMed ID: 24006261 [TBL] [Abstract][Full Text] [Related]
31. Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge. Georgiadis D; Yiotakis A Bioorg Med Chem; 2008 Oct; 16(19):8781-94. PubMed ID: 18790648 [TBL] [Abstract][Full Text] [Related]
32. The developmental and acute phases of insulin-induced laminitis involve minimal metalloproteinase activity. de Laat MA; Kyaw-Tanner MT; Nourian AR; McGowan CM; Sillence MN; Pollitt CC Vet Immunol Immunopathol; 2011 Apr; 140(3-4):275-81. PubMed ID: 21333362 [TBL] [Abstract][Full Text] [Related]
33. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Agapova OA; Ricard CS; Salvador-Silva M; Hernandez MR Glia; 2001 Mar; 33(3):205-16. PubMed ID: 11241738 [TBL] [Abstract][Full Text] [Related]
34. MMPs and ADAMs in neurological infectious diseases and multiple sclerosis. Muri L; Leppert D; Grandgirard D; Leib SL Cell Mol Life Sci; 2019 Aug; 76(16):3097-3116. PubMed ID: 31172218 [TBL] [Abstract][Full Text] [Related]
35. Comparative gene expression profiling of ADAMs, MMPs, TIMPs, EMMPRIN, EGF-R and VEGFA in low grade meningioma. Rooprai HK; Martin AJ; King A; Appadu UD; Jones H; Selway RP; Gullan RW; Pilkington GJ Int J Oncol; 2016 Dec; 49(6):2309-2318. PubMed ID: 27779709 [TBL] [Abstract][Full Text] [Related]
36. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition. Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140 [TBL] [Abstract][Full Text] [Related]
37. Potential role of hyaluronic acid on bone in osteoarthritis: matrix metalloproteinases, aggrecanases, and RANKL expression are partially prevented by hyaluronic acid in interleukin 1-stimulated osteoblasts. Mladenovic Z; Saurel AS; Berenbaum F; Jacques C J Rheumatol; 2014 May; 41(5):945-54. PubMed ID: 24737908 [TBL] [Abstract][Full Text] [Related]
38. Meprin β induces activities of A disintegrin and metalloproteinases 9, 10, and 17 by specific prodomain cleavage. Wichert R; Scharfenberg F; Colmorgen C; Koudelka T; Schwarz J; Wetzel S; Potempa B; Potempa J; Bartsch JW; Sagi I; Tholey A; Saftig P; Rose-John S; Becker-Pauly C FASEB J; 2019 Nov; 33(11):11925-11940. PubMed ID: 31381863 [TBL] [Abstract][Full Text] [Related]
39. H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure. Mishra PK; Tyagi N; Sen U; Givvimani S; Tyagi SC Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H451-6. PubMed ID: 19933416 [TBL] [Abstract][Full Text] [Related]